Pharmaceuticals

The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

Trend Stats

1-Month Return -5.53%
3-Month Return +4.85%
12-Month Return +30.81%
Volatility Score 1.6
RSI 48.3
ST Trend Down
LT Trend Up

Short-Term Trend

Down

The Short-Term Trend is a metric that gauges an ETF's short-term price trend.

Long-Term Trend

Up

The Long-Term Trend is a metric that gauges an ETF's long-term price trend.

Performance

Pharmaceuticals
S&P 500 Index

Components

Symbol Company Market Cap 12 mo return Performance over the past 12 months 3 mo return Performance over the past 3 months 1 mo return Performance over the past month Vol Score Our gauge of the ETF's recent volatility ST Trend A metric that gauges an ETF's short-term price trend LT Trend A metric that gauges an ETF's long-term price trend
LLY Eli Lilly & Co $1.1T +64.37% +5.10% -4.07% 2.4 Neutral Up
JNJ Johnson&Johnson $654B +54.32% +11.30% -0.70% 1.9 Neutral Up
ABBV AbbVie $467B +23.54% +9.49% -0.55% 2.0 Neutral Up
MRK Merck $367B +94.94% +19.30% -4.34% 2.2 Up Up
NVS Novartis Sp ADR $276B +21.19% -6.23% -9.08% 2.7 Down Down
AZN ASTRAZENECA $258B +14.86% -9.69% -1.82% 2.0 Neutral Down
NVO Nordisk Sp ADR-B $171B -26.87% -17.51% -20.26% 3.2 Down Down
PFE Pfizer $163B +29.13% +23.24% +0.35% 1.8 Up Up
BMY Bristol-MyersSqu $128B +49.31% +14.77% -7.45% 2.0 Down Up
MCK Mckesson $101B +14.40% +13.58% -4.15% 2.3 Down Neutral
GSK GSK Sp ADR $99B +27.95% -4.25% -5.43% 2.0 Down Down
SNY SANOFI SP ADR $99B -4.73% -1.65% -10.67% 1.7 Down Down
TAK TAKEDA PHARM SP ADR $60B +33.08% +20.51% +2.78% 1.5 Up Up
COR Cencora $59B +0.74% +7.17% -6.44% 2.3 Down Down
TEVA TEVA PHARMA IND $46B +113.69% +16.57% +2.86% 3.2 Up Up
HLN Haleon Sp ADR $41B +7.11% +0.56% -9.04% 2.0 Down Down
ZTS Zoetis-A $29B -49.54% -8.06% -8.07% 2.6 Down Down
VTRS Viatris $20B +93.93% +11.78% +6.64% 2.4 Up Up
JAZZ Jazz Pharmaceuti $15B +87.36% +5.19% -8.56% 2.5 Down Up
CORT Corcept Therapeu $13B +38.43% +36.99% -6.05% 4.7 Up Up
ELAN ELANC ANIML HLTH $11B +13.77% -8.45% -11.08% 3.3 Down Down
AXSM Axsome Therapeut $10B +67.09% -17.80% -5.06% 4.0 Down Down
DFTX DEFINIUM $4.9B +0.00% -19.25% -19.28% 5.5 Up Up
OGN Organon $3.6B +35.57% +2.08% -0.15% 0.3 Neutral Up
PRGO Perrigo $2.1B -21.33% +62.58% +8.69% 4.2 Up Up